Key facts
- It has raised $2.8M across 2 recorded rounds; the latest was Seed Round ($405K) in Nov 2025.
- Diabetes Reversal Group has filed 1 Form D with the SEC, most recently Jun 2025 ($2.4M sold to 24 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Diabetes Reversal Group
Funding rounds
2 roundsAbout Diabetes Reversal Group
Provider of non-drug diabetes reversal programs intended to serve adults with Type 2 diabetes through clinical and nutritional approaches in the United States. The company combines patented metabolic rebalancing protocols, personalized nutrition guidance, and physician collaboration to restore healthy blood sugar levels and reduce or eliminate medication dependency, enabling patients to achieve sustained remission and improved metabolic health.
- Sector
- Healthcare
- HQ
- Dallas, TX, United States
- Founded
- 2009
- Website
- diabetesreversalgroup.com/
- Ownership
- Privately Held (backing)
Diabetes Reversal Group doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Diabetes Reversal Group shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Diabetes Reversal Group in its N-PORT filings yet. We sweep new filings monthly.